Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths from the disease, but experts shared a warning

Una revisión internacional muestra que los análisis de sangre para el antígeno prostático específico pueden prevenir fallecimientos, aunque persisten dudas sobre riesgos y…